107 related articles for article (PubMed ID: 17825429)
1. B7-H3 regulates the development of experimental allergic conjunctivitis in mice.
Fukushima A; Sumi T; Fukuda K; Kumagai N; Nishida T; Yamazaki T; Akiba H; Okumura K; Yagita H; Ueno H
Immunol Lett; 2007 Oct; 113(1):52-7. PubMed ID: 17825429
[TBL] [Abstract][Full Text] [Related]
2. T-cell Ig and mucin domain-containing protein (Tim)-2 regulates murine allergic conjunctivitis during the effector phase.
Fukushima A; Sumi T; Fukuda K; Kumagai N; Nishida T; Okumura K; Akiba H; Yagita H; Ueno H
Immunol Lett; 2007 Jun; 110(2):133-8. PubMed ID: 17532058
[TBL] [Abstract][Full Text] [Related]
3. Roles of OX40 in the development of murine experimental allergic conjunctivitis: exacerbation and attenuation by stimulation and blocking of OX40.
Fukushima A; Yamaguchi T; Ishida W; Fukata K; Yagita H; Ueno H
Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):657-63. PubMed ID: 16431965
[TBL] [Abstract][Full Text] [Related]
4. Differential contributions of B7-1 and B7-2 to the development of murine experimental allergic conjunctivitis.
Sumi T; Fukushima A; Fukuda K; Kumagai N; Nishida T; Yagita H; Ueno H
Immunol Lett; 2007 Jan; 108(1):62-7. PubMed ID: 17109973
[TBL] [Abstract][Full Text] [Related]
5. Endogenous interleukin-10 produced by antigen-irrelevant cells promotes the development of experimental murine allergic conjunctivitis.
Fukushima A; Sumi T; Fukuda K; Kumagai N; Nishida T; Ueno H
Int Arch Allergy Immunol; 2007; 144(1):79-84. PubMed ID: 17505142
[TBL] [Abstract][Full Text] [Related]
6. Roles of galectin-9 in the development of experimental allergic conjunctivitis in mice.
Fukushima A; Sumi T; Fukuda K; Kumagai N; Nishida T; Okumura K; Akiba H; Yagita H; Ueno H
Int Arch Allergy Immunol; 2008; 146(1):36-43. PubMed ID: 18087160
[TBL] [Abstract][Full Text] [Related]
7. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production.
Schweitzer AN; Sharpe AH
J Immunol; 1998 Sep; 161(6):2762-71. PubMed ID: 9743334
[TBL] [Abstract][Full Text] [Related]
8. Activation of tumour-necrosis factor-related apoptosis-inducing ligand receptor enhances the severity of murine allergic conjunctivitis.
Sumi T; Ishida W; Okumura K; Yagita H; Fukushima A
Br J Ophthalmol; 2009 Jan; 93(1):110-5. PubMed ID: 18782797
[TBL] [Abstract][Full Text] [Related]
9. Endogenous IL-17 does not play a significant role in the development of experimental murine allergic conjunctivitis.
Fukushima A; Sumi T; Ishida W; Yamada J; Iwakura Y; Ueno H
Int Arch Allergy Immunol; 2008; 147(3):206-12. PubMed ID: 18594150
[TBL] [Abstract][Full Text] [Related]
10. TLR2 agonist ameliorates murine experimental allergic conjunctivitis by inducing CD4 positive T-cell apoptosis rather than by affecting the Th1/Th2 balance.
Fukushima A; Yamaguchi T; Ishida W; Fukata K; Ueno H
Biochem Biophys Res Commun; 2006 Jan; 339(4):1048-55. PubMed ID: 16337148
[TBL] [Abstract][Full Text] [Related]
11. The interaction between ICOS and B7RP-1 is not required for the development of experimental murine allergic conjunctivitis.
Fukushima A; Yamaguchi T; Ishida W; Fukata K; Yagita H; Ueno H
Biochem Biophys Res Commun; 2005 Dec; 338(4):1726-31. PubMed ID: 16289109
[TBL] [Abstract][Full Text] [Related]
12. Genetic background determines susceptibility to experimental immune-mediated blepharoconjunctivitis: comparison of Balb/c and C57BL/6 mice.
Fukushima A; Yamaguchi T; Ishida W; Fukata K; Taniguchi T; Liu FT; Ueno H
Exp Eye Res; 2006 Feb; 82(2):210-8. PubMed ID: 16102751
[TBL] [Abstract][Full Text] [Related]
13. Regulatory T cells participate in 4-1BB-mediated suppression of experimental allergic conjunctivitis.
Sumi T; Ishida W; Mittler RS; Yagita H; Taguchi O; Fukushima A
Int Arch Allergy Immunol; 2009; 148(4):305-10. PubMed ID: 19001790
[TBL] [Abstract][Full Text] [Related]
14. Distinct roles for B7-1 and B7-2 determinants during priming of effector CD8+ Tc1 and regulatory CD4+ Th2 cells for contact hypersensitivity.
Xu H; Heeger PS; Fairchild RL
J Immunol; 1997 Nov; 159(9):4217-26. PubMed ID: 9379016
[TBL] [Abstract][Full Text] [Related]
15. Treatment with FTY720 during the induction or effector phase suppresses the development of experimental allergic conjunctivitis in mice.
Sumi T; Fukushima A; Nishino K; Fukuda K; Kumagai N; Nishida T; Ueno H
Cell Biol Int; 2009 Apr; 33(4):534-41. PubMed ID: 19230848
[TBL] [Abstract][Full Text] [Related]
16. Participation of CD11b and F4/80 molecules in the conjunctival eosinophilia of experimental allergic conjunctivitis.
Fukushima A; Ishida W; Ojima A; Kajisako M; Sumi T; Yamada J; Tsuru E; Miyazaki J; Tominaga A; Yagita H
Int Arch Allergy Immunol; 2010; 151(2):129-36. PubMed ID: 19752566
[TBL] [Abstract][Full Text] [Related]
17. Role of interferon-gamma in a mouse model of allergic conjunctivitis.
Stern ME; Siemasko K; Gao J; Duong A; Beauregard C; Calder V; Niederkorn JY
Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3239-46. PubMed ID: 16123425
[TBL] [Abstract][Full Text] [Related]
18. The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses.
Suh WK; Gajewska BU; Okada H; Gronski MA; Bertram EM; Dawicki W; Duncan GS; Bukczynski J; Plyte S; Elia A; Wakeham A; Itie A; Chung S; Da Costa J; Arya S; Horan T; Campbell P; Gaida K; Ohashi PS; Watts TH; Yoshinaga SK; Bray MR; Jordana M; Mak TW
Nat Immunol; 2003 Sep; 4(9):899-906. PubMed ID: 12925852
[TBL] [Abstract][Full Text] [Related]
19. Role of VLA-4 in the development of allergic conjunctivitis in mice.
Fukushima A; Yamaguchi T; Ishida W; Fukata K; Ueno H
Mol Vis; 2006 Apr; 12():310-7. PubMed ID: 16617298
[TBL] [Abstract][Full Text] [Related]
20. B7-H3 promotes acute and chronic allograft rejection.
Wang L; Fraser CC; Kikly K; Wells AD; Han R; Coyle AJ; Chen L; Hancock WW
Eur J Immunol; 2005 Feb; 35(2):428-38. PubMed ID: 15682454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
